Catheter Precision Inc.
$ 0.41
4.46%
23 Jul - close price
- Market Cap 1,782,700 USD
- Current Price $ 0.41
- High / Low $ 0.42 / 0.35
- Stock P/E N/A
- Book Value 3.55
- EPS -10.48
- Next Earning Report 2026-08-10
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.23 %
- ROE -1.80 %
- 52 Week High 4.37
- 52 Week Low 0.31
About
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company is headquartered in Fort Mill, South Carolina.
Analyst Target Price
$2.00
Quarterly Earnings
| Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-18 | 2025-11-13 | 2025-08-11 | 2025-05-14 | 2025-03-31 | 2024-11-13 | 2024-08-14 | 2024-05-06 | 2024-03-28 | 2023-12-15 | 2023-09-28 | 2023-06-02 |
| Reported EPS | -1.3874 | -1.7 | -5.93 | -0.3585 | -1.3475 | -38.19 | -105.83 | -68.4 | -2.8 | -0.28 | -11.5 | -24.65 |
| Estimated EPS | None | 0.08 | 0.02 | 0.05 | -0.2 | -3.42 | -4.94 | -7.98 | -2.3 | -0.23 | -3.02 | -0.34 |
| Surprise | 0 | -1.78 | -5.95 | -0.4085 | -1.1475 | -34.77 | -100.89 | -60.42 | -0.5 | -0.05 | -8.48 | -24.31 |
| Surprise Percentage | None% | -2225% | -29750% | -817% | -573.75% | -1016.6667% | -2042.3077% | -757.1429% | -21.7391% | -21.7391% | -280.7947% | -7150% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-10 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: VTAK
2026-07-21 20:10:00
Flyte, the regional air mobility subsidiary of Catheter Precision (NYSE American: VTAK), has announced a strategic partnership with Blade Urban Air Mobility. This collaboration aims to feature Flyte's Cirrus Vision Jet fleet on Blade's platform, broadening distribution, increasing customer reach among premium travelers, and improving aircraft utilization. The non-exclusive agreement is expected to enhance Flyte's visibility and booking opportunities within the air mobility market.
2026-07-20 15:39:43
SEG JETS SPV I, LLC has disclosed a 9.79% beneficial ownership in Catheter Precision, Inc. (VTAK) through a Schedule 13G filing. This amounts to 1,065,620 shares of common stock, with shared voting and dispositive power. The ownership percentage is based on 10,880,868 shares outstanding as of July 17, 2026.
2026-07-19 23:14:57
This article provides financial data for Catheter Precision, Inc. (AMEX:VTAK), specifically focusing on its Enterprise Value to EBIT (EV/EBIT) forward metric. It details the current market status for the company on NYSE American and highlights its inclusion in TradingView's financial section. The content primarily serves as a snapshot of this particular financial valuation, without offering further analysis or commentary.
2026-07-19 16:10:11
The article presents the "Price to sales forward" metric for Catheter Precision, Inc. (FWB:4RM) on the Frankfurt Stock Exchange. It includes basic financial overview information for the company. The content appears to be a stub or a data point from a larger financial platform, offering a specific financial ratio without detailed analysis.
2026-07-16 00:15:19
Catheter Precision (NYSE American: VTAK) has successfully closed a private placement, raising $3.47 million through the sale of 3,470 shares of its newly designated Series C-3 Convertible Preferred Stock. Each share has a stated value of $1,000 and is convertible into common stock at an initial price of $0.632, subject to a $0.35 floor price and anti-dilution adjustments. The proceeds are earmarked for working capital, loan repayment, and general corporate purposes, and the conversion is expected to dilute existing common shareholders.
2026-07-15 20:15:00
Catheter Precision, Inc. (VTAK) reported preliminary unaudited record revenues of $1,037,000 for the second quarter ended June 30, 2026. This includes significant growth in both its MedTech and Flyte Vision Jet segments, with the latter up 61% sequentially and contributing $767,000. CEO David Jenkins expressed optimism about transitioning to a million-dollar month soon, driven by the Flyte acquisition and ongoing efforts to enhance shareholder value in the MedTech segment.
